Monomer Bio is a United States-based startup founded in 2021, focused on scaling data-driven biology with intelligent automation software. The company, with the slogan "Scaling data-driven biology with intelligent automation software," caters to the biotechnology and hardware industries, offering assistance to biology companies with lab automation. With a recent Seed Round investment of $5.60M at 31 January 2024, Monomer Bio secured funding from notable investors including Talis Capital, LifeX Labs, Notley Ventures, Kevin Mahaffey, and Amit Gupta. The team, comprising alumni from Google, MIT, Strateos, and UPenn, prides itself on having developed some of the world's largest fully automated labs from scratch. Whether it is advising on instrument procurement, facilitating seamless integration of instruments and software, or crafting custom solutions, Monomer Bio collaborates with biologists, engineers, technicians, and executive teams, demonstrating a passion for in-depth engagement with their clients. In summary, Monomer Bio's innovative approach and strong backing from prominent investors position the company as a key player in revolutionizing lab automation within the biotechnology and hardware sectors.
No recent news or press coverage available for Monomer Bio.